Predictive Factors of Downstaging of Hepatocellular Carcinoma Beyond the Milan Criteria Treated with Intra-arterial Therapies

Survival of patients with hepatocellular carcinoma treated by transarterial chemoembolisation (TACE) using Drug Eluting Beads. Implications for clinical practice and trial design

(2012) Marta Burrel et al.   JOURNAL OF HEPATOLOGY

Systematic review of outcome of downstaging hepatocellular cancer before liver transplantation in patients outside the Milan criteria

(2011) A. N. Gordon-Weeks et al.   BRITISH JOURNAL OF SURGERY

Management of hepatocellular carcinoma: An update

(2011) Jordi Bruix et al.   HEPATOLOGY

Modified RECIST (mRECIST) Assessment for Hepatocellular Carcinoma

(2010) Riccardo Lencioni et al.   SEMINARS IN LIVER DISEASE

Prospective Randomized Study of Doxorubicin-Eluting-Bead Embolization in the Treatment of Hepatocellular Carcinoma: Results of the PRECISION V Study

(2009) Johannes Lammer et al.   CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY

Quality Improvement Guidelines for Transhepatic Arterial Chemoembolization, Embolization, and Chemotherapeutic Infusion for Hepatic Malignancy

(2009) Daniel B. Brown et al.   JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY

Liver Transplantation for Hepatocellular Carcinoma: Results of Down-Staging in Patients Initially Outside the Milan Selection Criteria

(2008) M. Ravaioli et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Excellent outcome following down-staging of hepatocellular carcinoma prior to liver transplantation: An intention-to-treat analysis

(2008) Francis Y. Yao et al.   HEPATOLOGY

Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis

(2008) Vincenzo Mazzaferro et al.   LANCET ONCOLOGY